NCT06379217 2026-03-11NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.NovartisPhase 1 Active not recruiting31 enrolled
NCT02592707 2023-07-19Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETsIpsenPhase 1/2 Terminated40 enrolled 37 charts
NCT00401388 2018-03-07A Trial of Perifosine in Patients With Chemo-Insensitive SarcomasAEterna ZentarisPhase 2 Completed72 enrolled